Chemoradiotherapy versus short-course radiotherapy for response-adapted organ preservation in early and intermediate stage rectal cancer (STAR-TREC): 12-month results of an international, randomised, phase II/III trial

Bach, S.P., Sebag-Montefiore, D., Homer, V. et al. (24 more authors) (Accepted: 2026) Chemoradiotherapy versus short-course radiotherapy for response-adapted organ preservation in early and intermediate stage rectal cancer (STAR-TREC): 12-month results of an international, randomised, phase II/III trial. The Lancet Oncology. ISSN: 1470-2045 (In Press)

Metadata

Item Type: Article
Authors/Creators:
  • Bach, S.P.
  • Sebag-Montefiore, D.
  • Homer, V.
  • Gilbert, A.
  • Appelt, A.
  • Geh, I.
  • Beets, G.L.
  • Burger, J.
  • Angenete, E.
  • Baatrup, G.
  • Garm Spindler, K.L.
  • Haustermans, K.
  • Holman, F.
  • Kerkhof, E.M.
  • Lam, E.
  • Korsgen, S.
  • Martling, A.
  • Wolthuis, A.
  • Al-Najami, I.
  • Lind, P.
  • Peters, F.P.
  • Teo, M.
  • West, N.P. ORCID logo https://orcid.org/0000-0002-0346-6709
  • Gates, S.
  • Marijnen, C.A.M.
  • Hw de Wilt, J.
  • Collaborative, STAR-TREC
Dates:
  • Accepted: 1 May 2026
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Funding Information:
Funder
Grant number
Yorkshire Cancer Research Account Ref: 2UOLEEDS
L386-RA/2015/R2/003
Cancer Research UK Supplier No: 138573
19-0553/664406
Cancer Research UK Supplier No: 138573
RRCOER-Jun24/100004
Date Deposited: 01 Jun 2026 15:29
Last Modified: 01 Jun 2026 15:29
Status: In Press
Publisher: Elsevier
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)